|
||
J. Cell Biol.,
Volume 142, Number 2, July 27, 1998 557-571

* Division of Cancer Biology Research, Recent studies have demonstrated the importance of E-cadherin, a homophilic cell-cell adhesion
molecule, in contact inhibition of growth of normal
epithelial cells. Many tumor cells also maintain strong
intercellular adhesion, and are growth-inhibited by cell- cell contact, especially when grown in three-dimensional culture. To determine if E-cadherin could mediate
contact-dependent growth inhibition of nonadherent
EMT/6 mouse mammary carcinoma cells that lack
E-cadherin, we transfected these cells with an exogenous E-cadherin expression vector. E-cadherin expression in EMT/6 cells resulted in tighter adhesion of multicellular spheroids and a reduced proliferative fraction
in three-dimensional culture. In addition to increased
cell-cell adhesion, E-cadherin expression also resulted in
dephosphorylation of the retinoblastoma protein, an
increase in the level of the cyclin-dependent kinase
inhibitor p27kip1 and a late reduction in cyclin D1 protein. Tightly adherent spheroids also showed increased
levels of p27 bound to the cyclin E-cdk2 complex, and a
reduction in cyclin E-cdk2 activity. Exposure to E-cadherin-neutralizing antibodies in three-dimensional culture simultaneously prevented adhesion and stimulated
proliferation of E-cadherin transfectants as well as a
panel of human colon, breast, and lung carcinoma cell
lines that express functional E-cadherin. To test the
importance of p27 in E-cadherin-dependent growth inhibition, we engineered E-cadherin-positive cells to express inducible p27. By forcing expression of p27 levels
similar to those observed in aggregated cells, the stimulatory effect of E-cadherin-neutralizing antibodies
on proliferation could be inhibited. This study demonstrates that E-cadherin, classically described as an invasion suppressor, is also a major growth suppressor, and its ability to inhibit proliferation involves upregulation of the cyclin-dependent kinase inhibitor p27.
Department of Medicine and Department of
Medical Biophysics, University of Toronto, Toronto-Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada M4N 3M5
This article has been cited by other articles:
|
|